Scholarlink

Purpose <p>This study evaluated the feasibility, acceptability, and clinical utility of an electronic patient-reported outcome (ePRO) system for patients undergoing radiation therapy (RT) for prostate cancer in routine clinical practice.</p> Methods <p>A prospective observational study was conducted at the Medical University of Innsbruck among patients receiving RT for primary or recurrent prostate cancer. The ePRO system was designed to capture patient-reported symptoms and health-related quality of life throughout treatment and follow-up, aiming to standardize symptom monitoring and improve continuity of care. Patients completed questionnaires at baseline, during treatment, and in follow-up with feasibility defined as ≥ 75% of patients completing at least 75% of scheduled assessments. Patients’ acceptability was evaluated at baseline and at treatment end using self-developed questionnaires. Healthcare professionals’ (HCPs) perception of clinical utility of the system was measured with a self-developed questionnaire.</p> Results <p>Forty patients participated in the study with a median age of 71&#xa0;years. The ePRO system was feasible, with an average completion rate of 87%, exceeding the feasibility threshold. Patient acceptability was high, with 98% (39/40) expressing willingness to use it regularly. HCPs’ feedback was also positive, with all HCPs (100%, 8/8) reporting usefulness of the system in clinical care and 83% reporting that the system helped them in the clinical assessment of their patients.</p> Conclusion <p>The ePRO monitoring system was feasible and well-accepted among both patients and HCPs, demonstrating potential for continued use in routine clinical care. Further efforts are needed to optimize clinical integration and address barriers to ensure equitable access.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluating an electronic patient-reported outcome monitoring system in patients with prostate cancer in routine clinical care: a prospective observational study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月22日

查看全文
  • Samuel M. Vorbach,
  • Francesco Sparano,
  • Stefanie Kreissl,
  • David Riedl,
  • Manuel P. Sarcletti,
  • Angela Ginestet,
  • Bernhard Holzner,
  • Ute Ganswindt,
  • Jens Lehmann

摘要

Purpose

This study evaluated the feasibility, acceptability, and clinical utility of an electronic patient-reported outcome (ePRO) system for patients undergoing radiation therapy (RT) for prostate cancer in routine clinical practice.

Methods

A prospective observational study was conducted at the Medical University of Innsbruck among patients receiving RT for primary or recurrent prostate cancer. The ePRO system was designed to capture patient-reported symptoms and health-related quality of life throughout treatment and follow-up, aiming to standardize symptom monitoring and improve continuity of care. Patients completed questionnaires at baseline, during treatment, and in follow-up with feasibility defined as ≥ 75% of patients completing at least 75% of scheduled assessments. Patients’ acceptability was evaluated at baseline and at treatment end using self-developed questionnaires. Healthcare professionals’ (HCPs) perception of clinical utility of the system was measured with a self-developed questionnaire.

Results

Forty patients participated in the study with a median age of 71 years. The ePRO system was feasible, with an average completion rate of 87%, exceeding the feasibility threshold. Patient acceptability was high, with 98% (39/40) expressing willingness to use it regularly. HCPs’ feedback was also positive, with all HCPs (100%, 8/8) reporting usefulness of the system in clinical care and 83% reporting that the system helped them in the clinical assessment of their patients.

Conclusion

The ePRO monitoring system was feasible and well-accepted among both patients and HCPs, demonstrating potential for continued use in routine clinical care. Further efforts are needed to optimize clinical integration and address barriers to ensure equitable access.